Thermally reversible xyloglucan gels as vehicles for nasal drug delivery

52Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aim of this study was to investigate the potential application of thermosensitive gels formed by a xyloglucan polysaccharide derived from tamarind seed for nasal drug delivery. Xyloglucan that had been partially degraded by β-galactosidase to eliminate 45% of galactose residues formed gels at concentrations of 2.5% w/w at gelation temperatures decreasing over the range 2728°C. The in vitro release of ondansetron hydrochloride from the enzyme-degraded xyloglucan gels followed higuchi kinetics over a period of 5h at 34°C by anomalous transport mechanism. The ex vivo permeation of ondansetron hydrochloride from the gels was sustained. Histological examination of nasal mucosa following a single administration of the gels showed no evidence of mucosal damage. Finally, the bioavailability study in rabbits revealed that the absolute bioavailability of ondansetron hydrochloride was significantly increased from 28.64% in the case of the oral drug solution to 52.79% in the case of the nasal in situ gel. The results of this study suggest the potential of the enzyme-degraded xyloglucan gels as vehicles for nasal delivery of drugs. © 2012 Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Mahajan, H. S., Tyagi, V., Lohiya, G., & Nerkar, P. (2012). Thermally reversible xyloglucan gels as vehicles for nasal drug delivery. Drug Delivery, 19(5), 270–276. https://doi.org/10.3109/10717544.2012.704095

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free